FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16679511000001101: Urispas 200 tablets (Stephar (U.K.) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Mar 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
58662901000001111 Urispas 200 tablets (Stephar (U.K.) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58663001000001119 Urispas 200 tablets (Stephar (U.K.) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Urispas 200 tablets (Stephar (U.K.) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Stephar (U.K.) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Urispas 200 tablets (Stephar (U.K.) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Stephar (U.K.) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Stephar (U.K.) Ltd) Is a Product containing precisely flavoxate hydrochloride 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Stephar (U.K.) Ltd) Has active ingredient Flavoxate hydrochloride false Inferred relationship Existential restriction modifier
Urispas 200 tablets (Stephar (U.K.) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Stephar (U.K.) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Stephar (U.K.) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Stephar (U.K.) Ltd) Has specific active ingredient Flavoxate hydrochloride true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Stephar (U.K.) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Stephar (U.K.) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Stephar (U.K.) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Stephar (U.K.) Ltd) Is a Urispas true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Urispas 200 tablets (Stephar (U.K.) Ltd) 90 tablet Has AMP True Urispas 200 tablets (Stephar (U.K.) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start